Up to three quarters of older individuals in Latin America, India and China experienced significant decline in physical, cognitive,...
New research shows that Multiple Sclerosis (MS) patients undergoing anti-CD20 (aCD20) treatment – which depletes the B cells...
Millions of vulnerable people are to be offered a COVID-19 booster vaccine from next week as the government confirms it has accepted...
Researchers in the UK have warned that England experienced a rapid exponential increase this summer in the prevalence of severe...
In a recent paper, the researchers study the dynamics of SARS-CoV-2 infections on a geriatric hospital ward by whole genome sequencing....
This study revealed that the CV3-13 antibody can mediate Fc effector functions against S protein-expressing cells.
Researchers at Umeå University, Sweden, now demonstrate a method by which specific cell types in human organs can be studied...
In a recent paper, Australia's response to the COVID-19 pandemic is described, identifying the factors that contributed most...
The Ivy Brain Tumor Center at Barrow Neurological Institute, the largest early-phase drug development program for brain cancer...
Chronic lesions with inflamed rims, or "smoldering" plaques, in the brains of people with multiple sclerosis (MS) have been linked...